RC Outsourcing, LLC is recalling 2,669 Bevacizumab (1.75 mg/0.07 mL) intravitreal syringes due to a lack of assurance of sterility. This medication is typically administered as an injection into the eye by a healthcare professional in a hospital or office setting. The recall affects syringes with four specific lot numbers and beyond-use dates (BUD) ranging from October 6 to October 20, 2025.
A lack of sterility assurance in an injectable eye medication poses a serious risk of infection or inflammation within the eye, which can lead to vision loss or other severe complications. No specific injuries have been reported to date.
Quantity: 2,669 syringes; Label includes: Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.